101 related articles for article (PubMed ID: 38595987)
21. Inhibition of pannexin-1 channel activity by adiponectin in podocytes: Role of acid ceramidase activation.
Li G; Zhang Q; Hong J; Ritter JK; Li PL
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1246-1256. PubMed ID: 30077007
[TBL] [Abstract][Full Text] [Related]
22. Acid ceramidase deficiency: Farber disease and SMA-PME.
Yu FPS; Amintas S; Levade T; Medin JA
Orphanet J Rare Dis; 2018 Jul; 13(1):121. PubMed ID: 30029679
[TBL] [Abstract][Full Text] [Related]
23. Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy.
Choi SR; Lim JH; Kim MY; Kim EN; Kim Y; Choi BS; Kim YS; Kim HW; Lim KM; Kim MJ; Park CW
Metabolism; 2018 Aug; 85():348-360. PubMed ID: 29462574
[TBL] [Abstract][Full Text] [Related]
24. Could Ceramides Become the New Cholesterol?
Summers SA
Cell Metab; 2018 Feb; 27(2):276-280. PubMed ID: 29307517
[TBL] [Abstract][Full Text] [Related]
25. C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease.
Cozma C; Iurașcu MI; Eichler S; Hovakimyan M; Brandau O; Zielke S; Böttcher T; Giese AK; Lukas J; Rolfs A
Sci Rep; 2017 Jul; 7(1):6149. PubMed ID: 28733637
[TBL] [Abstract][Full Text] [Related]
26. Increased de novo ceramide synthesis and accumulation in failing myocardium.
Ji R; Akashi H; Drosatos K; Liao X; Jiang H; Kennel PJ; Brunjes DL; Castillero E; Zhang X; Deng LY; Homma S; George IJ; Takayama H; Naka Y; Goldberg IJ; Schulze PC
JCI Insight; 2017 May; 2(9):. PubMed ID: 28469091
[TBL] [Abstract][Full Text] [Related]
27. Enzyme replacement therapy for Farber disease: Proof-of-concept studies in cells and mice.
He X; Dworski S; Zhu C; DeAngelis V; Solyom A; Medin JA; Simonaro CM; Schuchman EH
BBA Clin; 2017 Jun; 7():85-96. PubMed ID: 28275553
[TBL] [Abstract][Full Text] [Related]
28. Inducible overexpression of adiponectin receptors highlight the roles of adiponectin-induced ceramidase signaling in lipid and glucose homeostasis.
Holland WL; Xia JY; Johnson JA; Sun K; Pearson MJ; Sharma AX; Quittner-Strom E; Tippetts TS; Gordillo R; Scherer PE
Mol Metab; 2017 Mar; 6(3):267-275. PubMed ID: 28271033
[TBL] [Abstract][Full Text] [Related]
29. Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort.
Havulinna AS; Sysi-Aho M; Hilvo M; Kauhanen D; Hurme R; Ekroos K; Salomaa V; Laaksonen R
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2424-2430. PubMed ID: 27765765
[TBL] [Abstract][Full Text] [Related]
30. Acid ceramidase and the treatment of ceramide diseases: The expanding role of enzyme replacement therapy.
Schuchman EH
Biochim Biophys Acta; 2016 Sep; 1862(9):1459-71. PubMed ID: 27155573
[TBL] [Abstract][Full Text] [Related]
31. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.
Laaksonen R; Ekroos K; Sysi-Aho M; Hilvo M; Vihervaara T; Kauhanen D; Suoniemi M; Hurme R; März W; Scharnagl H; Stojakovic T; Vlachopoulou E; Lokki ML; Nieminen MS; Klingenberg R; Matter CM; Hornemann T; Jüni P; Rodondi N; Räber L; Windecker S; Gencer B; Pedersen ER; Tell GS; Nygård O; Mach F; Sinisalo J; Lüscher TF
Eur Heart J; 2016 Jul; 37(25):1967-76. PubMed ID: 27125947
[TBL] [Abstract][Full Text] [Related]
32. Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study.
Cheng JM; Suoniemi M; Kardys I; Vihervaara T; de Boer SP; Akkerhuis KM; Sysi-Aho M; Ekroos K; Garcia-Garcia HM; Oemrawsingh RM; Regar E; Koenig W; Serruys PW; van Geuns RJ; Boersma E; Laaksonen R
Atherosclerosis; 2015 Dec; 243(2):560-6. PubMed ID: 26523994
[TBL] [Abstract][Full Text] [Related]
33. Ceramides - Lipotoxic Inducers of Metabolic Disorders.
Chaurasia B; Summers SA
Trends Endocrinol Metab; 2015 Oct; 26(10):538-550. PubMed ID: 26412155
[TBL] [Abstract][Full Text] [Related]
34. The ART of Lowering Ceramides.
Summers SA
Cell Metab; 2015 Aug; 22(2):195-6. PubMed ID: 26244926
[TBL] [Abstract][Full Text] [Related]
35. Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans.
Bergman BC; Brozinick JT; Strauss A; Bacon S; Kerege A; Bui HH; Sanders P; Siddall P; Kuo MS; Perreault L
Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E398-408. PubMed ID: 26126684
[TBL] [Abstract][Full Text] [Related]
36. Ceramide is upregulated and associated with mortality in patients with chronic heart failure.
Yu J; Pan W; Shi R; Yang T; Li Y; Yu G; Bai Y; Schuchman EH; He X; Zhang G
Can J Cardiol; 2015 Mar; 31(3):357-63. PubMed ID: 25746025
[TBL] [Abstract][Full Text] [Related]
37. Farber disease in infancy resembling juvenile idiopathic arthritis: identification of two new mutations and a good early response to allogeneic haematopoietic stem cell transplantation.
Torcoletti M; Petaccia A; Pinto RM; Hladnik U; Locatelli F; Agostoni C; Corona F
Rheumatology (Oxford); 2014 Aug; 53(8):1533-4. PubMed ID: 24614645
[No Abstract] [Full Text] [Related]
38. Elevation of ceramide and activation of secretory acid sphingomyelinase in patients with acute coronary syndromes.
Pan W; Yu J; Shi R; Yan L; Yang T; Li Y; Zhang Z; Yu G; Bai Y; Schuchman EH; He X; Zhang G
Coron Artery Dis; 2014 May; 25(3):230-5. PubMed ID: 24589572
[TBL] [Abstract][Full Text] [Related]
39. Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency.
Tarasov K; Ekroos K; Suoniemi M; Kauhanen D; Sylvänne T; Hurme R; Gouni-Berthold I; Berthold HK; Kleber ME; Laaksonen R; März W
J Clin Endocrinol Metab; 2014 Jan; 99(1):E45-52. PubMed ID: 24243630
[TBL] [Abstract][Full Text] [Related]
40. Systemic ceramide accumulation leads to severe and varied pathological consequences.
Alayoubi AM; Wang JC; Au BC; Carpentier S; Garcia V; Dworski S; El-Ghamrasni S; Kirouac KN; Exertier MJ; Xiong ZJ; Privé GG; Simonaro CM; Casas J; Fabrias G; Schuchman EH; Turner PV; Hakem R; Levade T; Medin JA
EMBO Mol Med; 2013 Jun; 5(6):827-42. PubMed ID: 23681708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
